Skip to main content

Table 2 The results of univariate and multivariate cox proportional hazard analysis in this study

From: A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma

Variable

Univariate cox regression

Multivariate cox regression

P-value

Hazard ratio (95% confidence interval)

P-value

Hazard ratio (95% confidence interval)

Age

0.968

0.96 (0.11–8.62)

–

–

WBC

0.289

3.34 (0.36–31.03)

–

–

NEUT

0.187

4.27 (0.49–36.86)

–

–

PLT

0.509

2.59 (0.15–43.65)

–

–

HGB

0.586

2.14 (0.14–32.82)

–

–

CEA

0.013

12.64 (1.72–92.68)

0.0196

20.49 (1.62–258.62)

Gender

    

Male

    

Female

0.782

1.16 (0.41–3.30)

–

–

Smoking

    

No

    

Yes

0.523

1.37 (0.52–3.61)

–

–

Drinking

    

No

    

Yes

0.475

0.66 (0.22–2.04)

–

–

WHO pathologic typea

    

Type I

    

Type II

0.769

0.74 (0.09–5.73)

–

–

Type III

0.181

0.23 (0.03–1.98)

–

–

T stage

    

T1

    

T2

0.841

0.75 (0.05–12.05)

0.7037

1.78 (0.09–34.18)

T3

0.167

4.34 (0.54–34.77)

0.0089

44.81 (2.59–774.89)

T4a

0.014

14.91 (1.72–128.92)

0.0007

253.43 (10.21–6287.79)

N stage

    

N0

    

N1

0.568

1.94 (0.20–18.69)

0.1164

8.17 (0.59–112.41)

N2

0.438

2.26 (0.29–17.65)

0.1435

5.63 (0.56–57.00)

N3

0.057

9.09 (0.94–88.07)

0.0004

352.82 (13.69–9094.31)

Overall stage

    

II

    

III

0.998

82,836,007.61

–

–

IVa

0.997

488,669,656.57

–

–